Affiliation: | a Department of Pharmacology and Physiology, Medical College of Pennsylvania/Hahnemann University, Philadelphia, PA, USA b Division of Neurobiology, MRC Laboratory of Molecular Biology, Hills Road, Cambridge, CB2 2QH, UK c Department of Biochemistry, Cambridge University, Cambridge, CB2 1GA, UK d Current address: Université Louis Pasteur Strasbourg I, Faculté de Pharmacie, Illkirch-Graffenstaden, France e Current address: Department of Molecular Biology, The Scripps Research Institute, La Jolla, CA, USA |
Abstract: | Nicotinic acetylcholine receptors and 5-HT3 serotonin receptors are present on presynaptic nerve terminals in the striatum, where they have been shown to be involved in the regulation of dopamine release. Here, we explored the possibility that both receptor systems function on the same individual nerve terminals in the striatum, as assessed by confocal imaging of synaptosomes. On performing sequential stimulation, nicotine (500 nM) induced changes in [Ca2+]i in most of the synaptosomes (80%) that had previously responded to stimulation with the 5-HT3 receptor agonist m–chlorophenylbiguanide (mCPBG; 100 nM), whereas mCPBG induced [Ca2+]i responses in approximately half of the synaptosomes that showed responses on nicotinic stimulation. The 5-HT3 receptor–specific antagonist tropisetron blocked only the mCPBG–induced responses, but not the nicotinic responses on the same synaptosomes. Immunocytochemical staining revealed extensive co-localization of the 5-HT3 receptor with the 4 nicotinic receptor subunit on the same synaptosomes, but not with the 3 and/or 5 subunits. Immunoprecipitation studies indicate that the 5-HT3 receptor and the 4 nicotinic receptor subunit do not interact on the nerve terminals. The presence of nicotinic and 5-HT3 receptors on the same presynaptic striatal nerve terminal indicates a convergence of cholinergic and serotonergic systems in the striatum. |